Advertisement
Screener

Quince Therapeutics, Inc. (QNCX) ROE

Quince Therapeutics, Inc. (QNCX) ROE

  • 2026-06-30: ROE 261.79%.
  • 2026-03-31: ROE -210.80%.
  • 2025-12-31: ROE 235.14%.
  • 2025-09-30: ROE -5380.45%.

Complete source-backed roe history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30261.79%
2026-03-31-210.80%
2025-12-31235.14%
2025-09-30-5380.45%
2025-06-30-417.77%
2025-03-31-326.73%
2024-12-31-188.51%
2024-09-30-118.54%
2024-06-30-113.10%
2024-03-31-40.82%
2023-12-31-36.89%
2023-09-30-33.71%
2023-06-30-35.21%
2023-03-31-46.86%
2022-12-31-51.36%
2022-09-30-66.51%
2022-06-30-74.70%
2022-03-31-83.19%
2021-12-31-75.85%
2021-09-30-65.66%
2021-06-30-61.16%
2021-03-31-52.89%
2020-12-31-44.61%
2020-09-30-36.53%
2020-06-30-27.75%
2020-03-31-22.23%
2019-12-31-32.02%
2019-09-30-22.05%
2019-06-30-15.22%
2019-03-3138.87%
2018-12-3138.24%

Annual ROE

DateROE
2025-12-31235.14%
2024-12-31-188.51%
2023-12-31-36.89%
2022-12-31-51.36%
2021-12-31-75.85%
2020-12-31-44.61%
2019-12-31-32.02%
2018-12-3138.24%

Similar stocks

Stock NameCountryMarket CapPE Ratio
CEL SCI CORP (CVM)United States$0.030B-0.81
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
Scilex Holding Co (SCLX)United States$0.042B-0.14
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioCardia, Inc. (BCDA)United States$0.016B
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
LeonaBio, Inc. (LONA)United States$0.047B-0.61